Susman Robert Graham

Susman Robert Graham is listed in filings as Director at Immunovant, Inc.. This profile follows SEC Form 4 activity through May 1, 2026, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from May 5, 2025 to May 1, 2026. Reported amounts are shown as $68.0K to $560.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.